{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:28:41Z","timestamp":1793471321004,"version":"4.5.0"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"\n Importance<\/jats:title>\n Evidence supports using antiplatelet therapy in patients with acute ischemic stroke. However, neurological deterioration remains common under the currently recommended antiplatelet regimen, leading to poor clinical outcomes.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To determine whether intravenous tirofiban administered within 24 hours of stroke onset prevents early neurological deterioration in patients with acute noncardioembolic stroke compared with oral aspirin.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This investigator-initiated, multicenter, open-label, randomized clinical trial with blinded end-point assessment was conducted at 10 comprehensive stroke centers in China between September 2020 and March 2023. Eligible patients were aged 18 to 80 years with acute noncardioembolic stroke within 24 hours of onset and had a National Institutes of Health Stroke Scale (NIHSS) score of 4 to 20.<\/jats:p>\n <\/jats:sec>\n \n Intervention<\/jats:title>\n Patients were assigned randomly (1:1) to receive intravenous tirofiban or oral aspirin for 72 hours using a central, web-based, computer-generated randomization schedule; all patients then received oral aspirin.<\/jats:p>\n <\/jats:sec>\n \n Main Outcome<\/jats:title>\n The primary efficacy outcome was early neurological deterioration (increase in NIHSS score \u22654 points) within 72 hours after randomization. The primary safety outcome was symptomatic intracerebral hemorrhage within 72 hours after randomization.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 425 patients were included in the intravenous tirofiban (n\u2009=\u2009213) or oral aspirin (n\u2009=\u2009212) groups. Median (IQR) age was 64.0 years (56.0-71.0); 124 patients (29.2%) were female, and 301 (70.8%) were male. Early neurological deterioration occurred in 9 patients (4.2%) in the tirofiban group and 28 patients (13.2%) in the aspirin group (adjusted relative risk, 0.32; 95% CI, 0.16-0.65;\n P<\/jats:italic>\n \u2009=\u2009.002). No patients in the tirofiban group experienced intracerebral hemorrhage. At 90-day follow-up, 3 patients (1.3%) in the tirofiban group and 3 (1.5%) in the aspirin group died (adjusted RR, 1.15; 95% CI, 0.27-8.54;\n P<\/jats:italic>\n \u2009=\u2009.63), and the median (IQR) modified Rankin scale scores were 1.0 (0-1.25) and 1.0 (0-2), respectively (adjusted odds ratio, 1.28; 95% CI, 0.90-1.83;\n P<\/jats:italic>\n \u2009=\u2009.17).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In patients with noncardioembolic stroke who were seen within 24 hours of symptom onset, tirofiban decreased the risk of early neurological deterioration but did not increase the risk of symptomatic intracerebral hemorrhage or systematic bleeding.<\/jats:p>\n <\/jats:sec>\n \n Trial Registration<\/jats:title>\n \n ClinicalTrials.gov Identifier:\n NCT04491695<\/jats:ext-link>\n <\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaneurol.2024.0868","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T11:32:24Z","timestamp":1713785544000},"page":"594","source":"Crossref","is-referenced-by-count":81,"title":["Effects of Tirofiban on Neurological Deterioration in Patients With Acute Ischemic Stroke"],"prefix":"10.1001","volume":"81","author":[{"given":"Wenbo","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing, China"},{"name":"Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanhui","family":"Li","sequence":"additional","affiliation":[{"name":"Stroke Center, Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjie","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ordos Central Hospital, Ordos, Inner Mongolia, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Neurology, Sinopharm North Hospital, Baotou, Inner Mongolia, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Third People\u2019s Hospital of Hubei Province, Wuhan, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanyang Second People\u2019s Hospital, Nanyang, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoming","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tongliao City Hospital, Tongliao, Inner Mongolia, China"},{"name":"Department of Neurology, Affiliated Hospital of Inner Mongolia Minzu University, Inner Mongolia, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Traditional Chinese Medicine Hospital of Tianjin Beichen District, Tianjin, China"},{"name":"Department of Neurology, Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changming","family":"Wen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nanyang Central Hospital, Nanyang, Henan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qianfo Mountain Hospital of Shandong University, Jinan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Statistics, University of Minnesota at Twin Cities, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqing","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuwei","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunming","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"TREND Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Ding","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Wang","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Hao","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bujv","family":"Bian","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanqing","family":"Feng","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Xie","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wen","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlin","family":"Yang","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhao","family":"Li","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejiang","family":"Gui","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hao","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiong","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhao","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutao","family":"Liu","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanchao","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Si","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Qiao","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Xu","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yuan","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Shao","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Dai","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchao","family":"Huo","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhou","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufei","family":"Cheng","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Hou","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Wang","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Yan","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajuan","family":"Fu","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Zang","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiping","family":"Zhao","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Wen","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Lv","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Lian","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Kang","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaihang","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiyu","family":"Guo","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhua","family":"Zhao","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Liu","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zheng","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangsheng","family":"Ke","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shao","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Tao","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbing","family":"Ke","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"He","sequence":"additional","affiliation":[{"name":"for the TREND Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"noi240019r1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/jnnp-2014-308327","article-title":"Incidence, causes and predictors of neurological deterioration occurring within 24 h following acute ischaemic stroke: a systematic review with pathophysiological implications.","volume":"86","author":"Seners","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"noi240019r2","doi-asserted-by":"publisher","DOI":"10.1177\/17562864221147743","article-title":"Early neurological deterioration in patients with acute ischemic stroke: a prospective multicenter cohort study.","volume":"16","author":"Liu","year":"2023","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"noi240019r3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4103\/bc.bc_68_21","article-title":"Neurological deterioration and computed tomography perfusion changes with increased time to peak in lacunar stroke.","volume":"8","author":"Farooqui","year":"2022","journal-title":"Brain Circ"},{"issue":"16","key":"noi240019r4","doi-asserted-by":"publisher","first-page":"e2178","DOI":"10.1212\/WNL.0000000000010603","article-title":"Neurologic deterioration in patients with acute ischemic stroke or transient ischemic attack.","volume":"95","author":"Park","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"noi240019r5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.4103\/bc.bc_56_22","article-title":"Branch atheromatous disease and treatment.","volume":"8","author":"Duan","year":"2022","journal-title":"Brain Circ"},{"issue":"5","key":"noi240019r6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1177\/1076029614551823","article-title":"Clopidogrel plus aspirin prevents early neurologic deterioration and improves 6-month outcome in patients with acute large artery atherosclerosis stroke.","volume":"21","author":"Wang","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"issue":"10","key":"noi240019r7","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1007\/s00415-018-8998-1","article-title":"Aspirin plus clopidogrel may reduce the risk of early neurologic deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.","volume":"265","author":"Yi","year":"2018","journal-title":"J Neurol"},{"issue":"5","key":"noi240019r8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40265-019-01078-0","article-title":"Platelet glycoprotein IIb\/IIIa receptor inhibitor tirofiban in acute ischemic stroke.","volume":"79","author":"Yang","year":"2019","journal-title":"Drugs"},{"issue":"25","key":"noi240019r9","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban.","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"issue":"3","key":"noi240019r10","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.jacc.2005.11.012","article-title":"Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abciximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST trial.","volume":"47","author":"Bolognese","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"noi240019r11","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1161\/01.CIR.0000016359.94919.16","article-title":"Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency: results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial.","volume":"105","author":"Januzzi","year":"2002","journal-title":"Circulation"},{"issue":"9","key":"noi240019r12","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1161\/STROKEAHA.110.599662","article-title":"Safety of tirofiban in acute ischemic stroke: the SaTIS trial.","volume":"42","author":"Siebler","year":"2011","journal-title":"Stroke"},{"issue":"12","key":"noi240019r13","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1161\/STROKEAHA.119.026240","article-title":"Low-dose tirofiban treatment improves neurological deterioration outcome after intravenous thrombolysis.","volume":"50","author":"Wu","year":"2019","journal-title":"Stroke"},{"issue":"10","key":"noi240019r14","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1161\/STROKEAHA.116.014413","article-title":"Safety and preliminary efficacy of early tirofiban treatment after alteplase in acute ischemic stroke patients.","volume":"47","author":"Li","year":"2016","journal-title":"Stroke"},{"issue":"12","key":"noi240019r15","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1161\/STROKEAHA.117.019193","article-title":"Low-dose tirofiban improves functional outcome in acute ischemic stroke patients treated with endovascular thrombectomy.","volume":"48","author":"Zhao","year":"2017","journal-title":"Stroke"},{"issue":"22","key":"noi240019r16","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1056\/NEJMoa2214299","article-title":"Tirofiban for stroke without large or medium-sized vessel occlusion.","volume":"388","author":"Zi","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"noi240019r17","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"7","key":"noi240019r18","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"45","author":"Kernan","year":"2014","journal-title":"Stroke"},{"issue":"2","key":"noi240019r19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1136\/svn-2020-000378","article-title":"Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases.","volume":"5","author":"Liu","year":"2020","journal-title":"Stroke Vasc Neurol"},{"issue":"13","key":"noi240019r20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","article-title":"Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.","volume":"359","author":"Hacke","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"noi240019r21","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1161\/01.CIR.88.3.1264","article-title":"Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction.","volume":"88","author":"Marber","year":"1993","journal-title":"Circulation"},{"issue":"10","key":"noi240019r22","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1097\/HJH.0000000000000675","article-title":"Blood pressure variability and the development of early neurological deterioration following acute ischemic stroke.","volume":"33","author":"Chung","year":"2015","journal-title":"J Hypertens"},{"issue":"23","key":"noi240019r23","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1212\/01.wnl.0000326064.42186.7e","article-title":"High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke.","volume":"71","author":"Castellanos","year":"2008","journal-title":"Neurology"},{"issue":"1-2","key":"noi240019r24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000113732","article-title":"Steno-occlusive arterial disease and early neurological deterioration in acute ischemic stroke.","volume":"25","author":"Ois","year":"2008","journal-title":"Cerebrovasc Dis"},{"issue":"7","key":"noi240019r25","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s00415-008-0820-z","article-title":"Acute stroke unit care and early neurological deterioration in ischemic stroke.","volume":"255","author":"Roquer","year":"2008","journal-title":"J Neurol"},{"key":"noi240019r26","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.785836","article-title":"Efficacy and safety of tirofiban in clinical patients with acute ischemic stroke.","volume":"12","author":"Han","year":"2022","journal-title":"Front Neurol"},{"issue":"7","key":"noi240019r27","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1136\/jnnp-2014-308401","article-title":"Outcome of patients with occlusions of the internal carotid artery or the main stem of the middle cerebral artery with NIHSS score of less than 5: comparison between thrombolysed and non-thrombolysed patients.","volume":"86","author":"Heldner","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2817537\/jamaneurology_zhao_2024_oi_240019_1719522267.77283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T11:09:44Z","timestamp":1719832184000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2817537"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2024.0868","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}